Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patientsJournal of Cellular and Molecular Medicine, 2020-09, Vol.24 (18), p.10274-10278 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.15674 ;PMID: 32713161Digital Resources/Online E-Resources |
2 |
Material Type: Article
|
![]() |
Mortality and pre‐hospitalization use of low‐dose aspirin in COVID‐19 patients with coronary artery diseaseJournal of Cellular and Molecular Medicine, 2021-01, Vol.25 (2), p.1263-1273 [Peer Reviewed Journal]2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16198 ;PMID: 33336936Digital Resources/Online E-Resources |
3 |
Material Type: Article
|
![]() |
Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID‐19: A Retrospective StudyJournal of cellular and molecular medicine, 2021-04, Vol.25 (7), p.3484-3497 [Peer Reviewed Journal]2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;COPYRIGHT 2021 Wiley Subscription Services, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16431 ;PMID: 33694276Full text available |
4 |
Material Type: Article
|
![]() |
MiR‐320a contributes to atherogenesis by augmenting multiple risk factors and down‐regulating SRFJournal of cellular and molecular medicine, 2015-05, Vol.19 (5), p.970-985 [Peer Reviewed Journal]2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2015 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12483 ;PMID: 25728840Full text available |
5 |
Material Type: Article
|
![]() |
A common variant of RIP3 promoter region is associated with poor prognosis in heart failure patients by influencing SOX17 bindingJournal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5317-5328 [Peer Reviewed Journal]2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14408 ;PMID: 31148336Full text available |
6 |
Material Type: Article
|
![]() |
Genetic risk scores to predict the prognosis of chronic heart failure patients in Chinese HanJournal of cellular and molecular medicine, 2020-01, Vol.24 (1), p.285-293 [Peer Reviewed Journal]2019 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14722 ;PMID: 31670483Full text available |
7 |
Material Type: Article
|
![]() |
miR‐1322 regulates Ch REBP expression via binding a 3′‐ UTR variant (rs1051943)Journal of cellular and molecular medicine, 2018-11, Vol.22 (11), p.5322-5332 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13805Full text available |
8 |
Material Type: Article
|
![]() |
miR‐1322 regulates ChREBP expression via binding a 3′‐UTR variant (rs1051943)Journal of cellular and molecular medicine, 2018-11, Vol.22 (11), p.5322-5332 [Peer Reviewed Journal]2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13805 ;PMID: 30079502Full text available |